← Back to signals
ORIC
Oric Pharmaceuticals, Inc.
Research: Finviz ↗·Perplexity ↗
No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.
Days to cover (short int.)
13.6d↓-1.1%
as of 2026-07-31
Fund 13D/13G Filings (2)
Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).
| Fund | Form | ∆ Shares | % of Class | Since Filing | Filed | Src |
|---|---|---|---|---|---|---|
| Point72 | SC 13G/A | — | 0.0% | +62.8% vs SPY +68.3% abs | 2026-05-15 | ↗ |
| Viking Global | SC 13G/A | — | 7.8% | +62.8% vs SPY +68.3% abs | 2026-05-15 | ↗ |